Cambridge Depersonalization Scale: What It Measures and Its Limits
Author: Angela Bogdanova · Published: October 9, 2026 · Editorial Policy
Research cluster: Dissociation & Dissociative Disorders · Written by Artificial Sapiens
The Cambridge Depersonalization Scale (CDS) is a 29-item self-report questionnaire used to describe how frequently certain depersonalization and derealization experiences occur and how long they last. Its standard reference period is the previous six months. It is particularly useful when a clinician or researcher needs a structured account of experiences that people may struggle to express in everyday language. The instrument was developed by Mauricio Sierra and German E. Berrios and first published in 2000 in Psychiatry Research. Read the original development and validation study.
A CDS result describes a pattern of reported experiences. It is not a diagnosis, proof of a particular cause, evidence of trauma, or confirmation of depersonalization-derealization disorder (DPDR). Interpretation requires the person's history, functional impact, context, clinical interview, and assessment of other possible explanations. A major systematic review of dissociation measures published in 2025 rated the CDS among the more strongly supported instruments for depersonalization, while emphasizing substantial gaps in measurement science across the field.
What Is the Cambridge Depersonalization Scale?
The CDS is a symptom-measurement instrument. Each of its 29 descriptions addresses a subjective experience associated with depersonalization or derealization. The respondent estimates both how often it occurred and how long it persisted during the reference period. Rather than asking someone simply whether they 'have dissociation,' it gathers a more detailed profile of the phenomenology and persistence of detachment-related experiences.
The original spelling is Cambridge Depersonalisation Scale, reflecting the British publication. Cambridge Depersonalization Scale is the common American-English spelling. Both names refer to the same original CDS-29 instrument. The abbreviation CDS can also refer to unrelated scales in other fields, so clinical documentation should specify the full instrument name and version.
The original study evaluated 77 participants: 35 patients diagnosed with depersonalization disorder under DSM-IV, 22 patients with anxiety disorders, and 20 patients with temporal lobe epilepsy. Its authors reported useful separation of those particular groups, together with high internal consistency and split-half reliability. Those findings support the instrument's historical development. A 77-person, selected clinical sample cannot establish a universal diagnostic rule for contemporary, heterogeneous populations.
What Experiences Does the CDS Measure?
Depersonalization describes an alteration in how a person experiences their own thoughts, feelings, body, or sense of being present, often described as distance from oneself. Derealization describes an alteration in how surroundings are experienced: familiar places, people, or objects may seem unreal, dreamlike, visually strange, or unusually distant. These experiences can be distressing even while the person understands that their subjective impression does not reflect a literal transformation of reality. The clinical difference between these experiences and a disorder depends on recurrence, distress, impairment, context, and diagnostic criteria. Merck Manual's clinician-reviewed account provides that clinical context.
The CDS encompasses more than the popular description of feeling 'outside your body.' Its content covers changes in bodily self-experience, perceived emotional response, autobiographical or imaginative experience, and alienation from surroundings. This breadth is important because some people report emotional numbing or changes in familiar perception more prominently than a classic observer-of-myself sensation.
Altered body and self-experience
Relevant experiences may include an unusual sense of bodily distance, unfamiliarity with one's own actions or physical sensations, or a sense of functioning automatically. The distinction is between the felt quality of experience and any objectively observed neurological loss of function. A questionnaire score cannot settle the cause of bodily symptoms or substitute for a neurological examination when one is indicated.
Emotional numbing and reduced felt response
Some respondents describe knowing that an emotion should be present while being unable to experience its ordinary felt intensity. This can overlap with depression, severe stress, anxiety, medication effects, and other conditions. The CDS records the experience; it does not establish that emotional numbing arose from a particular dissociative mechanism.
Changes in memory experience and mental imagery
A person may remember that an event occurred while experiencing the memory as distant, unfamiliar, or lacking its former emotional immediacy. This subjective change in the quality of recollection differs from objective inability to retrieve autobiographical information, which can raise different diagnostic questions. The CDS should not be used to infer dissociative amnesia, inaccurate memory, or suppressed memories.
Alienation from surroundings
Derealization-related descriptions concern altered familiarity and vividness of the external environment. Surroundings may feel staged or dreamlike even when visual and auditory senses function normally. Researchers have used CDS items to examine how these experiences cluster, including an exploratory factor analysis in clinically diagnosed patients.
How Does the 29-Item Scale Work?
The standard questionnaire asks about the preceding six months. Each item has a frequency response and a duration response. In the conventional CDS-29 scoring system, frequency is scored from 0 to 4 and duration from 0 to 6; when an experience is never reported, the associated duration contributes zero. The two components are added for each item, yielding a maximum of 10 points per item and a total possible range of 0 to 290. The measurement structure appears in the original instrument study and subsequent research applications.
The scoring approach gives weight to both recurrence and persistence. Two people may describe broadly similar experiences but receive different totals if one reports brief, rare episodes and the other reports recurrent or sustained experiences. The resulting number is an aggregate of ordinal questionnaire ratings. It is not a biological measurement, a count of distinct episodes, or a continuous objective record of the last six months.
The six-month reference period is essential to interpretation. A participant who experiences a sudden, intense episode today may not score in the same way as someone with lower-intensity but chronic detachment. Research teams occasionally adapt the reference interval to study shorter-term changes; scores from modified intervals should be identified as modified and should not automatically be compared with six-month norms. Researchers should document the exact version, administration period, language, missing-item handling, and scoring protocol.
The full questionnaire is not reproduced here. Clinical and research users should obtain an authorized instrument version and its administration instructions from an appropriate source rather than relying on a copied, edited, incomplete, or unverified online questionnaire.
What Does a Cambridge Depersonalization Scale Score Mean?
The total indicates the reported frequency and persistence of experiences represented by the 29 items. Higher totals generally indicate a greater burden of those self-reported experiences within the scale's content. A lower total means fewer or briefer endorsed experiences on the questionnaire. Neither result independently answers whether a person meets formal criteria for a dissociative disorder or requires a particular treatment.
Is 70 a diagnostic cutoff?
A threshold around 70 is widely cited from the original line of validation work. Reporting on that literature, the Italian cross-cultural validation paper describes approximately 75.7% sensitivity and 87.2% specificity at a score of 70 for the studied diagnostic contrasts. Sensitivity means the proportion of people with the target condition identified by that rule in the validation sample; specificity means the proportion of comparison participants classified below the threshold. Neither number is a person's probability of having the disorder.
Those percentages depend on how the participants were selected and which clinical diagnoses formed the comparison group. They also depend on the historical diagnostic definition, setting, language version, and reference standard. Applying the same threshold across different populations, or interpreting it as an official DSM-5-TR requirement, exceeds what the original evidence demonstrates.
The Japanese validation study, based on 59 participants including just 12 people with depersonalization disorder, found a different apparent optimum of 60 when comparing its clinical and control groups. A Spanish validation study described an apparent threshold of 71 for its own setting. These results illustrate sampling and language dependence rather than a competition to identify one universally correct number.
Why a positive result cannot establish a diagnosis
Any cutoff produces possible false positives and false negatives. Positive predictive value changes with how common the diagnosed condition is in the population being evaluated, even when sensitivity and specificity appear good. In a broadly screened group where clinical DPDR is uncommon, many high-scoring people may have other causes of symptoms or may not meet full diagnostic criteria.
A person below a historical threshold may still need evaluation for distressing, intermittent symptoms. A person above it may have symptoms associated with panic attacks, depression, medication or substance effects, migraine, seizure disorders, or another context. Neither conclusion can be drawn from the number alone. Clinical assessment evaluates the actual experience, timeline, impairment, and differential diagnosis rather than treating the CDS as a pass/fail test.
Can scores measure improvement?
Repeated administrations may help a clinician or study track how questionnaire-reported experiences change over time if the same validated version and timeframe are used. Interpretation should examine whether changes exceed ordinary measurement noise, whether functioning and distress changed, and whether treatment or external circumstances affected the respondent. A decrease in total score alone does not prove a particular treatment worked, and an increase does not establish deterioration across every dimension of mental health.
The 2025 COSMIN-informed review found gaps in measurement-error and reliability investigation across dissociation instruments. Therefore, a universal minimal clinically important difference for the CDS should not be asserted without population-specific validation. Clinical notes should report actual scores, version, interval, and the patient's account instead of translating a change into an unvalidated severity category.
What Does Research Say About Reliability and Validity?
Reliability asks whether a measure produces reasonably consistent results under appropriate conditions. Validity asks whether evidence supports the interpretation and proposed use of its scores. These are related questions. A scale can be internally consistent and still be insufficiently specific to determine the cause of symptoms or the presence of a disorder.
Original psychometric findings
The Sierra and Berrios development study reported Cronbach's alpha of 0.89 and split-half reliability of 0.92. It also found a correlation of approximately 0.80 with the depersonalization subscale of the Dissociative Experiences Scale in its sample. Those are promising reliability and convergent-validity findings, especially for a novel instrument measuring a complex subjective experience. They do not establish perfect diagnostic classification or representativeness beyond the recruitment settings.
Cross-language studies
The German adaptation study used a sample of 91 inpatients and reported an internal-consistency alpha of 0.95 while comparing questionnaire findings with interview-based assessment. The Japanese study reported an alpha of 0.94 in 59 participants. The Greek validation study found high internal consistency and a test-retest intraclass correlation near 0.88 in its research context. The Spanish study reported a weaker test-retest estimate of approximately 0.39 despite other favorable indicators. Distinct study methods and populations limit simple comparison.
A translated questionnaire needs semantic and cultural validation; word-for-word equivalence is not enough. People may describe self-unreality, emotion, body experience, and environmental strangeness differently across languages and cultural traditions. A cutoff supported for an English psychiatric sample should not be exported to every translated version without evidence.
Is the scale one-dimensional or multidimensional?
Researchers have identified meaningful patterns within CDS responses, but the exact factor structure is not completely stable across populations. In 138 patients diagnosed with depersonalization disorder, investigators derived four factors: anomalous body experience, emotional numbing, anomalous subjective recall, and alienation from surroundings. The dimensions help clinicians and researchers understand why two respondents with similar totals may have different symptom profiles.
A subsequent study of 534 trauma-exposed college students did not reproduce the previously published factor solutions and supported a two-factor interpretation focused on unreality/detachment and emotional/physical numbing. This is clinically important: the number and content of statistical subscales may vary with sample and method. Subscale scores should follow a specified validated model and should not be presented as independent formal diagnoses.
What did the 2025 systematic review conclude?
Wainipitapong and colleagues systematically assessed 170 studies covering 44 dissociation measures and 14 adapted versions, applying COSMIN principles. The CDS was among instruments with comparatively stronger evidence for its relevant construct. At the same time, no instrument met every criterion for strong psychometric properties and high methodological quality; content validity and several reliability domains remained underexamined. The review's conclusions support careful use rather than either blanket rejection or unqualified reliance on the questionnaire.
Clinical Use: When Might the CDS Be Helpful?
A clinician may use the CDS to give structure to a conversation about difficult-to-name experiences, document a baseline symptom profile, explore the relative prominence of bodily detachment and derealization, or monitor self-reported changes alongside clinical outcomes. A research team may use it to characterize a study sample or analyze correlations with perception, emotion, attention, and other measures. A peer-reviewed experimental study demonstrates its use as a research measure rather than a substitute for diagnostic interviewing.
The most useful administration begins with a clear explanation of what the questionnaire asks and what its results can and cannot establish. Clinicians should confirm that respondents understand the reference period and response choices, note language barriers and current cognitive limitations, and review unusual or highly distressing answers in conversation. Scoring should follow the chosen version's manual. The clinician should document substantial modifications, missing answers, or reasons why the measure was unsuitable.
Researchers should report recruitment method, diagnostic confirmation procedures, exclusion criteria, age range, language version, distribution of scores, selected cutoff rationale, missing-data strategy, and measurement properties in the relevant sample. For longitudinal work, they should report whether the reference interval was altered, whether repeat-measure validity was evaluated, and whether observed score changes meaningfully track functioning.
What the CDS Cannot Determine
The scale cannot distinguish with certainty between DPDR disorder and detachment symptoms that arise in panic, depression, PTSD, substance use, migraine, seizure disorders, or other conditions. It does not measure the complete range of dissociative identity disturbance, clinically significant amnesia, or functional neurological symptoms. Its scores cannot establish when an experience first began or whether an identifiable historical event caused it.
The CDS also cannot verify traumatic events, recover missing memories, identify concealed identity states, confirm psychosis, or infer abnormalities in brain scans. It is a description of endorsed phenomenology rather than an instrument for establishing the factual history behind that phenomenology. Any clinical discussion of autobiographical memories must remain separate from claims about the historical accuracy of particular memories.
Because the scale emphasizes a six-month self-report, recall bias is possible. Responses may vary with current distress, mood, interpretation of wording, attention, the person's ability to recall episode duration, and whether they have been given explanatory labels. A respondent may also find some items difficult to distinguish from common sensory, cognitive, or emotional experiences. These effects require thoughtful interpretation rather than automatic invalidation.
CDS Versus Other Dissociation Assessments
The CDS focuses on the subjective experiences and temporal pattern of depersonalization and derealization. The Dissociative Experiences Scale (DES-II) samples a broader set of dissociative experiences and is often used as a screening questionnaire. These instruments serve overlapping but different purposes; their total scores are not interchangeable. A high CDS score should not be converted into an inferred DES-II score or a diagnosis of dissociative identity disorder.
The Structured Clinical Interview for DSM Dissociative Disorders (SCID-D) is a clinician-administered diagnostic interview designed to assess dissociative phenomena and related diagnostic questions. The Multidimensional Inventory of Dissociation (MID) addresses a broader range of experiences, including disturbances of memory and identity. No self-report questionnaire should replace a qualified diagnostic assessment when the question concerns a formal disorder. The review of dissociation measures evaluates the research status of multiple instruments without declaring any one questionnaire suitable for every clinical question. For instrument-specific distinctions, read SCID-D interview and Multidimensional Inventory of Dissociation (MID).
For an acute, rapidly changing state of dissociation, a six-month questionnaire may miss the timing and immediate severity that matter clinically. Measures designed for states, brief clinical descriptions, and direct observation can be more suitable for that specific question. Selecting a measure begins with the intended use, population, reference period, and what decisions could follow from the result.
How Is Depersonalization-Derealization Disorder Diagnosed?
Under DSM-5-TR, clinical DPDR disorder involves persistent or recurrent depersonalization, derealization, or both; intact reality testing during the experience; clinically significant distress or functional impairment; and exclusion of substance, medical, or alternative psychiatric explanations. Under ICD-11, depersonalization-derealization disorder is also recognized within dissociative disorders, with classification language and clinical descriptions provided by WHO. The two systems should be read on their own terms rather than forced into a single item-by-item checklist. See the WHO ICD-11 clinical description manual and the Merck clinician reference.
The phrase 'intact reality testing' means that a person generally recognizes a sense of unreality as a change in their experience, not evidence that the external world has literally ceased to exist. Clinicians still explore the entire presentation carefully. Panic symptoms, psychotic experiences, obsessive rumination, mood symptoms, sleep disruption, and cognitive changes can overlap phenomenologically, but they are assessed through distinct clinical questions. A numerical CDS result cannot adjudicate these differences.
Medical assessment may be indicated when symptoms are new, atypical, occur with neurological signs, or follow substance exposure or medication changes. Clinicians may consider examination and targeted testing based on history, such as when seizures or other neurological conditions are plausible. The correct workup is individualized; a CDS threshold does not order or replace MRI, EEG, medication review, or toxicology evaluation.
Can Trauma Cause a High CDS Score?
Depersonalization and derealization may occur in contexts of trauma and stress, and some people with trauma-related conditions endorse elevated CDS symptoms. The association does not make traumatic exposure a universal cause of every depersonalization experience. Panic, overwhelming anxiety, depressive states, sleep deprivation, medication effects, substances, and neurological disorders can all be relevant in an individual case. The evaluation asks what actually happened rather than inferring an etiology from a score.
Research involving trauma-exposed samples can clarify symptom structure or associations, but it does not demonstrate that a particular respondent's history included a specific event. For the separate trauma-centered question, see the published Childhood Trauma and Dissociation article, whose canonical owner is the Childhood Trauma cluster.
What Should You Do if You Have Concerning Results?
If you completed a genuine CDS through a professional or research setting, keep a copy of the score and administration details, and discuss them with the clinician or study team. Describe what the experiences feel like, when they occur, how long they last, whether you can continue normal tasks, and whether there are panic symptoms, medication or substance changes, sleep problems, or neurological symptoms. Specific examples are more useful than trying to interpret the total as a diagnosis.
If detachment is persistent, distressing, disruptive, or increasingly frequent, a qualified health professional can assess possible causes and appropriate care. For a sudden episode with loss of consciousness, a new seizure, severe confusion, acute neurological deficits, or another urgent medical concern, seek prompt emergency medical evaluation. Online questionnaires are especially unsuitable for triaging such events.
For day-to-day support, steady sleep, reducing known substance triggers, managing excessive stress, and using simple orientation or grounding strategies may help some people feel more settled. Any strategy that increases distress should be reconsidered with a clinician. Research on treatments and immediate coping deserves condition-specific discussion; the CDS itself neither prescribes treatment nor identifies the best therapy or medication.
Frequently Asked Questions
Is the Cambridge Depersonalization Scale a diagnostic test?
It is a symptom questionnaire with research support and possible clinical assessment applications. It cannot independently establish DSM-5-TR or ICD-11 diagnostic criteria, functional impairment, clinical exclusions, or the underlying cause of symptoms. The original validation compared results with clinical diagnoses rather than making the questionnaire itself the diagnostic standard.
How many questions are in the original CDS?
The standard CDS-29 contains 29 experiential descriptions, with frequency and duration ratings for each one. Short or modified forms may appear in individual studies; the specific form and its evidence should be identified.
What is the highest possible CDS score?
The total conventional CDS-29 range is 0 to 290, reflecting up to 10 points for each of 29 items. A high number indicates a higher level of endorsed experiences, not a degree of confirmed brain pathology or a severity grade recognized by DSM-5-TR.
Does a score of 70 mean I have DPDR?
No. Seventy is a historically studied classification threshold whose performance depended on the study population. Later Japanese and Spanish studies reported different candidate thresholds. Diagnosis requires individual assessment, including distress or impairment and exclusion of alternative causes.
Can a score below 70 rule out the disorder?
No. A cutoff below perfect sensitivity misses some cases even in its validation sample. It also cannot capture every variation in episode timing or symptom history. Clinically important experiences warrant evaluation regardless of a screening threshold.
What is the difference between depersonalization and derealization on the CDS?
Depersonalization centers on the experienced relationship to self, body, emotion, or thought. Derealization concerns altered experienced familiarity or reality of surroundings. CDS items span both, and the distinction is explored more fully during clinical interviewing.
Can the CDS diagnose dissociative identity disorder?
No. The CDS measures depersonalization-related experiences and does not assess the full diagnostic requirements for DID. Identity discontinuity, amnesia, differential diagnosis, and clinical context require a separate evaluation.
Do the four CDS factors represent four illnesses?
No. The four-factor model describes clusters of questionnaire responses in one research sample. Other studies found different statistical structures, including a two-factor result in college students. These are models of symptom organization, not official clinical diagnoses.
Can I take the Cambridge Depersonalization Scale online?
Versions circulate online, but availability does not demonstrate that a copy is complete, correctly scored, up to date, authorized, or appropriate for independent interpretation. Prefer a documented, validated version in a professional or research setting.
Is the CDS suitable for children or adolescents?
The original study centered on adults aged 18 to 60. Application to younger populations requires age-appropriate assessment, relevant validation, developmental interpretation, and safeguarding. Adult cutoff figures should not be assumed valid for children.
Can the CDS monitor treatment progress?
It can help track self-reported symptoms under comparable administration conditions, especially when paired with clinical follow-up. It is insufficient by itself to measure functional recovery, treatment safety, remission, or whether a particular intervention caused a change.
Can panic attacks, cannabis, or neurological conditions affect responses?
Yes. Depersonalization and derealization experiences can occur in anxiety and panic states, with substances, and in certain neurological contexts. The clinical differential diagnosis guidance explains why evaluation must consider these possibilities rather than attributing a score automatically to DPDR disorder.
Why do research articles use different CDS thresholds?
Thresholds are estimated against different reference diagnoses, participant groups, languages, and study designs. Some research uses cutoffs for group recruitment or exploratory comparisons rather than clinical diagnosis. Always read what the threshold was intended to detect and in whom it was validated.
Is the CDS the same as the Dissociative Experiences Scale?
No. The CDS concentrates on depersonalization and derealization phenomena, while the DES samples broader dissociative experiences. Their scores and clinical uses should not be substituted for one another. See the systematic review for the instruments' comparative evidence.
Related Articles
SCID-D Interview: Clinical Assessment of Dissociative Disorders — clinician-led diagnostic assessment, its uses, and its limits.
Multidimensional Inventory of Dissociation (MID): Uses and Limitations — a broader self-report dissociation inventory and its limits.
Childhood Trauma and Dissociation: What Is the Connection? — the evidence and boundaries of trauma-centered dissociation research.
Neurosis vs Dissociation: Historical Concepts and Modern Diagnostic Categories — how historical psychiatric terminology relates to contemporary dissociation concepts.
References
Blevins, C. A., Witte, T. K., & Weathers, F. W. (2013). Factor structure of the Cambridge Depersonalization Scale in trauma-exposed college students. Journal of Trauma & Dissociation, 14(3), 288–301. Source
Ciaunica, A., Ayache, J., Haggard, P., Nakul, E., Bonnet, E., & Auvray, M. (2024). Explicit and implicit sense of agency in depersonalisation experiences. Scientific Reports, 14, 15396. Source
Kontoangelos, K., et al. (2016). Reliability, validity, and psychometric properties of the Greek translation of the Cambridge Depersonalization Scale (CDS). Materia Socio-Medica, 28(5), 387–391. Source
Merck Manual Professional Edition. (2026). Depersonalization/derealization disorder. Clinical reference.
Michal, M., et al. (2004). The measurement of the depersonalisation-derealisation syndrome with the German version of the Cambridge Depersonalisation Scale. Psychotherapie, Psychosomatik, Medizinische Psychologie, 54, 367–374. https://doi.org/10.1055/s-2004-828296.
Migliorini, V., et al. (2012). Italian (cross cultural) adaptation and validation of the Cambridge Depersonalization Scale (CDS). Epidemiology and Psychiatric Sciences. Source
Molina Castillo, J. J., et al. (2006). Cross-cultural adaptation and validation of the Cambridge Depersonalisation Scale. Actas Españolas de Psiquiatría, 34, 185–192. PubMed PMID 16736392.
Sierra, M., Baker, D., Medford, N., & David, A. S. (2005). Unpacking the depersonalization syndrome: An exploratory factor analysis on the Cambridge Depersonalization Scale. Psychological Medicine, 35, 1523–1532. https://doi.org/10.1017/S0033291705005325.
Sierra, M., & Berrios, G. E. (2000). The Cambridge Depersonalisation Scale: A new instrument for the measurement of depersonalisation. Psychiatry Research, 93, 153–164. https://doi.org/10.1016/S0165-1781(00)00100-1.
Sugiura, M., Hirosawa, M., Tanaka, S., Nishi, Y., Yamada, Y., & Mizuno, M. (2009). Reliability and validity of a Japanese version of the Cambridge depersonalization scale as a screening instrument for depersonalization disorder. Psychiatry and Clinical Neurosciences, 63, 314–321. https://doi.org/10.1111/j.1440-1819.2009.01939.x.
Wainipitapong, S., Millman, L. M., Huang, X., Wieder, L., Terhune, D. B., & Pick, S. (2025). Assessing dissociation: A systematic review and evaluation of existing measures. Journal of Psychiatric Research, 181, 91–98. https://doi.org/10.1016/j.jpsychires.2024.11.040.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Official WHO publication.